Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Exonate to launch phase 2b trial of EXN407 for diabetic eye disease

Exonate to launch phase 2b trial of EXN407 for diabetic eye disease
p p Read More

CLEAR-DE study to assess topical therapy for non-proliferative diabetic retinopathy

July 29, 2025 News

Moderna’s updated COVID-19 vaccine receives positive EMA opinion

Moderna’s updated COVID-19 vaccine receives positive EMA opinion
p p Read More

CHMP recommends authorization for LP.8.1-targeting vaccine ahead of 2025-2026 season

July 28, 2025 News

Akari Therapeutics advances research on novel PH1 payload for targeted cancer therapy

Akari Therapeutics advances research on novel PH1 payload for targeted cancer therapy
p p Read More

Akari Therapeutics has reaffirmed its commitment to advancing research on PH1, a novel spliceosome modulator payload used in […]

July 24, 2025 News

Kling Bio partners with Sanofi to accelerate antibody discovery

Kling Bio partners with Sanofi to accelerate antibody discovery
p p Read More

Collaboration aims to advance next-generation therapeutics and vaccines

July 24, 2025 News

4TEEN4 begins trial of antibody therapy for cardiogenic shock

4TEEN4 begins trial of antibody therapy for cardiogenic shock
p p Read More

First patient dosed in phase 1b/2a study of procizumab

July 23, 2025 News

Ovagen breakthrough boosts yellow fever vaccine yields

Ovagen breakthrough boosts yellow fever vaccine yields
p p Read More

Irish biotech’s germ-free egg platform could help close global shortfall

July 23, 2025 News

PhoreMost unveils platform to streamline molecular glue drug discovery

PhoreMost unveils platform to streamline molecular glue drug discovery
p p Read More

GlueSEEKER enables rational design of targeted protein degraders

July 22, 2025 News

AlzeCure to present promising pain therapy ACD440 at NeuPSIG 2025

AlzeCure to present promising pain therapy ACD440 at NeuPSIG 2025
p p Read More

Clinical results from phase 2 study highlight analgesic effects in neuropathic pain patients

July 21, 2025 News

Ezmekly becomes first approved EU therapy for NF1-PN in children and adults

Ezmekly becomes first approved EU therapy for NF1-PN in children and adults
p p Read More

EC grants conditional marketing authorisation to Merck and SpringWorks Therapeutics

July 21, 2025 News

Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression

Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression
p p Read More

First patient dosed in BUOY-1 study targeting MDD with or without anxious distress

July 17, 2025 News

Posts navigation

Posts pagination

« Previous 1 … 8 9 10 … 70 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy